loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2016_267___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    AbbVie Inc

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 AbbVie Inc. North Chicago US (1)

    filter

    01 Erythromycin, Process 2 (1)

    filter

    01 U.S.A (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    AbbVie Inc. North Chicago US

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Erythromycin, Process 2

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 2016-267 - Rev 00
    Valid
    Chemical
    2022-03-14
    179
    Abbvie Company Banner

    Iran Expo

    Not Confirmed

    envelop Contact Supplier

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2016-267 - Rev 00 of Abbvie Inc. North Chicago Us

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2016-267 - Rev 00 of Abbvie Inc. North Chicago Us 1

    20

    Abbvie Inc. North Chicago Us, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their significant offerings is Erythromycin, Process 2, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2016-267 - Rev 00

    This Chemical Type CEP, issued on March 14, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 179 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY